A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein Transporters

• Published in: Nanomaterials (Basel, Switzerland) Switzerland), 2021-10, Vol.11 (11), p.2858
• Main Authors: Razzaq, Sobia, Rauf, Aisha, Raza, Abida, Akhtar, Sohail, Tabish, Tanveer A., Sandhu, Mansur Abdullah, Zaman, Muhammad, Ibrahim, Ibrahim M., Shahnaz, Gul, Rahdar, Abbas, Díez-Pascual, Ana M.
• Format: Article
• Language: English
• Subjects: Anticancer properties; Apoptosis; Bioavailability; Biocompatibility; biodistribution; Cancer; Drug delivery systems; Drugs; Efflux; Enzymes; Fluorescence; fluorescent micelles; Glycoproteins; Hyaluronic acid; Intestine; Micelles; Microscopy; mucoadhesion; Multidrug resistance; Oral administration; Organs; P-Glycoprotein; P-gP efflux; Paclitaxel; Papain; Penetration; Pharmacokinetics; Polyethylene glycol; Polymers; resistance; Rheology; Solid tumors; Toxicity testing; Toxicology; Tumors; Viscoelasticity; Viscosity
• ISSN: 2079-4991; 2079-4991
• DOI: 10.3390/nano11112858

P-glycoprotein (P-gP) efflux-mediated multidrug resistance is a fundamental aspect of chemotherapeutic failure in oncology. The current study aims to deliver paclitaxel (PTX) specifically at the target site with improved in vivo efficacy of poorly permeable PTX against solid tumors. Multifunctional polymeric micelles as targeted delivery have been devised for loading and release of PTX. Mucoadhesion, permeation enhancement, oral pharmacokinetics, biodistribution, and toxicological studies were carried out to fully elucidate the therapeutic outcomes of the polymeric micelles. Ex vivo permeation studies indicated a 7.89-fold enhancement in the permeation of PTX with mucopermeating papain functionalized thiolated redox micelles (PT-R-Ms) compared to the pure PTX. Moreover, PT-R-Ms exhibited a higher percentage of apoptotic cells (42.9 ± 0.07%) compared to pure PTX. Biodistribution studies revealed that fluorotagged PT-RMs accumulated in excised tumors and organs. The higher fluorescence intensity indicated the mucopermeation of micelles across the intestine. The orally administered PT-R-Ms efficiently overcome intestinal barriers and inhibit the P-gP efflux pump, resulting in increased bioavailability of PTX (up to 8-fold) in comparison to pure PTX. The enhanced anti-tumor efficacy and reduced toxic effects are key aspects of efficient cancer therapy. This study demonstrates that the use of mucopermeating PT-R-Ms is an encouraging approach to overwhelm the permeation barrier in cancer treatment.